Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113156237 | 11315623 | 7 | F | 20150608 | 20160825 | 20150728 | 20160829 | EXP | CA-ROCHE-1605625 | ROCHE | 57.87 | YR | F | Y | 75.00000 | KG | 20160829 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113156237 | 11315623 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 536 | MG | SOLUTION FOR INFUSION | |||||||
| 113156237 | 11315623 | 2 | C | SALAZINE | SULFASALAZINE | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 3 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 5 | C | ACTONEL | RISEDRONATE SODIUM | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 6 | C | BACLOFEN. | BACLOFEN | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 8 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 9 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 10 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 11 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 12 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 113156237 | 11315623 | 13 | C | OXYCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113156237 | 11315623 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113156237 | 11315623 | OT |
| 113156237 | 11315623 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113156237 | 11315623 | Anaphylactic reaction | |
| 113156237 | 11315623 | Exposure to toxic agent | |
| 113156237 | 11315623 | Increased appetite | |
| 113156237 | 11315623 | Pneumonia | |
| 113156237 | 11315623 | Stress | |
| 113156237 | 11315623 | Weight decreased | |
| 113156237 | 11315623 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113156237 | 11315623 | 1 | 20150422 | 0 |